HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016; New Report Launched
"HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the HIV / AIDS Report is to understand the market and pipeline status of the drugs around the HIV / AIDS to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Report provides the historical and forecasted...
View full press release